ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,167Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1290

$1.81M Total Retail Price of All Prescriptions

Rank: 13 out of 1290

433 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 433 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 11,540 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

53% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$120 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
NEXIUM 665 482 1 34
PLAVIX 655 460 2 32
SINGULAIR 603 403 3 85
CELEBREX 538 399 4 111
ADVAIR DISKUS 460 305 5 37
OMEPRAZOLE 399 290 6 2
CRESTOR 348 255 7 17
LIDODERM 290 192 8 113
NAMENDA 280 247 9 27
ZOLPIDEM TARTRATE 269 208 10 15
DIOVAN 241 161 11 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 241 166 11 92
IBUPROFEN 240 167 13 74
DONEPEZIL HCL 210 185 14 13
FINASTERIDE 205 179 15 40
TRAMADOL HCL 204 153 16 25
CLOPIDOGREL 203 146 17 24
LYRICA 200 145 18 94
MEGESTROL ACETATE 199 185 R 19 198
LISINOPRIL 191 151 20 5
TAMSULOSIN HCL 170 131 21 11
METOPROLOL TARTRATE 163 124 22 7
NOVOLIN 70-30 156 102 23 233
PENTOXIFYLLINE 156 121 23 251
GLYBURIDE-METFORMIN HCL 154 129 R 25 147
METFORMIN HCL 139 87 26 10
DIOVAN HCT 139 111 26 112
AMLODIPINE BESYLATE 137 116 28 3
VOLTAREN 135 97 29 107
DICYCLOMINE HCL 132 103 30 202
SYMBICORT 130 91 31 109
ACTOS 129 109 32 182
LEXAPRO 124 93 33 173
GABAPENTIN 121 112 34 8
LEVOTHYROXINE SODIUM 120 100 35 4
BACLOFEN 120 84 35 122
SIMVASTATIN 118 98 37 1
MECLIZINE HCL 117 114 38 159
HYDROCHLOROTHIAZIDE 115 97 39 20
DETROL LA 114 101 40 351
TRICOR 112 63 41 194
ATENOLOL 110 96 42 18
CILOSTAZOL 108 91 43 237
LOVAZA 104 78 44 131
CYMBALTA 99 83 45 59
ESCITALOPRAM OXALATE 97 82 46 63
DOVONEX 95 66 47 536
DICLOFENAC SODIUM 94 77 48 77
POTASSIUM CHLORIDE 89 67 49 35
RESTASIS 85 57 50 119
SOLARAZE 85 64 50 305
FUROSEMIDE 83 51 52 9
AMMONIUM LACTATE 82 77 53 276
AVODART 80 77 54 69
PROAIR HFA 80 59 54 73
EXELON 78 62 56 95
LANTUS 78 75 56 67
SURE COMFORT 77 57 58 214
AMLODIPINE BESYLATE-BENAZEPRIL 76 67 59 166
ENALAPRIL MALEATE 74 57 60 62
NYSTATIN-TRIAMCINOLONE 73 46 61 302
FLUTICASONE PROPIONATE 72 41 62 26
LANSOPRAZOLE 70 64 63 181
GLIPIZIDE 68 61 64 81
MELOXICAM 68 49 64 31
FLOVENT HFA 66 42 66 421
CLONIDINE HCL 66 62 66 66
CLOBETASOL PROPIONATE 64 44 68 117
DIGOXIN 64 64 68 51
RANITIDINE HCL 63 57 70 49
BUMETANIDE 63 58 70 196
ALLOPURINOL 61 41 72 60
INSULIN SYRINGE 60 46 73 76
CARVEDILOL 56 55 74 12
ABILIFY 56 38 74 114
NASONEX 55 22 76 168
LUNESTA 51 34 77 370
MEGACE ES 50 35 R 78 480
MONTELUKAST SODIUM 50 38 78 189
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.